FibroBiologics, Inc. Common Stock (FBLG) NASDAQ

0.23

-0.0145(-5.99%)

Updated at December 31 01:36PM

Currency In USD

Valuation

Market Cap65.75M
Enterprise Value62.32M
P/E Ratio-0.68
PEG Ratio0.01
Price/Sales Ratio17.64
Price/Book Ratio10.47
Enterprise/Revenue21.01
Enterprise/EBITDA-0.93

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-23.87
Operating Margin-29.03

Management Effectiveness

Return On Assets-0.95
Return On Equity-6.09

Income Statement

Revenue0
Revenue/Share0.01
Gross Profit0
EBITDA-10.57M
Net Income-11.16M
Diluted EPS-0.34

Balance Sheet

Total Cash4.87M
Total Cash/Share0.23
Total Debt7.11M
Total Debt/Equity12.53
Current Ratio0.93
Book Value Per Share0.02

Price History

52-Week Change-88.42
52-Week High2.34
52-Week Low0.22
Moving Average 50 Days0.32
Moving Average 200 Days0.64

Statistics

Average Volume1.47M
Shares Outstanding41.92M
% Held by Institutions13.85

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A